How do clinicians respond to the sizable volume of patients with end-stage renal disease but who don't want conventional care?
Creating a novel population of mutant tissues helps scientists deduce the cause of polycystic kidney disease and other cilia-linked illnesses.
This is the Center for Dialysis Innovation’s third award in the ongoing international KidneyX competition.
A SpaceX cargo launch slated for Thursday, June 3, will deliver an experiment on kidney stone formation in microgravity.
At-home dialysis is a U.S. priority to stem the growing burden of care that involves people with chronic kidney disease.
Teams in Seattle and Cleveland are pursuing an experiment to regenerate crucial cells and create a new therapy model.
The role in a national trial could validate the technology as a predictor for drug therapies’ effectiveness against patients’ kidney diseases.
A UW Medicine patient was integral to generating global recommendations for care involving diabetes and chronic kidney disease.
The Center for Dialysis Innovation earns acclaim for a porous synthetic graft intended to make the blood-cleansing process safer and more reliable.
Investigators are dejected that the large study did not support treating this patient population with a familiar, inexpensive drug.
